XML 46 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Shareholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common shares
Ordinary Shares
Common shares
Deferred Shares
Common shares
Deferred B Shares
Common shares
Deferred C Shares
Additional Paid in Capital
Accumulated other comprehensive gain/(loss)
Accumulated deficit
Beginning balance at Dec. 31, 2018 $ 232,642 $ 2 $ 0 $ 118 $ 0 $ 361,311 $ (15,488) $ (113,301)
Beginning balance, shares at Dec. 31, 2018   40,145,617 34,425 88,893,548 1      
Stockholders' Equity                
Share-based compensation expense 7,365         7,365    
Restricted shares - forfeited, shares   (302)            
Exercise of stock options 4         4    
Exercise of stock options, shares   2,126            
Unrealized gain on foreign currency translation 5,051           5,051  
Net loss (27,179)             (27,179)
Ending balance at Mar. 31, 2019 217,883 $ 2 $ 0 $ 118 $ 0 368,680 (10,437) (140,480)
Ending balance, shares at Mar. 31, 2019   40,147,441 34,425 88,893,548 1      
Beginning balance at Dec. 31, 2019 254,839 $ 2 $ 0 $ 118 $ 0 500,560 (8,691) (237,150)
Beginning balance, shares at Dec. 31, 2019   44,983,006 34,425 88,893,548 1      
Stockholders' Equity                
Share-based compensation expense 6,235         6,235    
Restricted shares - forfeited, shares   (50)            
Exercise of stock options $ 24         24    
Exercise of stock options, shares 14,976 14,976            
Issuance of ordinary shares, net of issuance costs $ 73,953 $ 1       73,952    
Issuance of shares, net of issuance costs (shares)   7,250,000            
Unrealized gain on foreign currency translation (17,701)           (17,701)  
Net loss (29,873)             (29,873)
Ending balance at Mar. 31, 2020 $ 287,478 $ 3 $ 0 $ 118 $ 0 $ 580,772 $ (26,392) $ (267,023)
Ending balance, shares at Mar. 31, 2020   52,247,932 34,425 88,893,548 1